Barry Buckland serves as Executive at Enumeral Biomedical Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Barry Buckland has executed 6 insider transactions totaling $92.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 11, 2024 involved exercising options for 11,793 shares valued at $18.8K.
Barry Buckland currently holds 38,967 shares of Enumeral Biomedical Holdings, Inc. (ENUM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barry Buckland has been a net seller of ENUM stock. They have purchased $0 and sold $92.7K worth of shares.
Barry Buckland's most recent insider trade was on Jun 11, 2024, when they sold 11,793 shares at $1.59 per share.
Get notified when new Form 4 filings are submitted
| 27,174 |
| $N/A |
| Discretionary |
| Dec 3, 2019 | DYAI | $3.5K | Option Exercise | 2,500 | $1.39 | Discretionary |
| Dec 3, 2019 | DYAI | $92.7K | Sale | 15,000 | $6.18 | Discretionary |
| Dec 3, 2019 | DYAI | $17.4K | Option Exercise | 12,500 | $1.39 | Discretionary |
| Dec 9, 2016 | ENUM | $6.8K | Option Exercise | 52,000 | $0.13 | Discretionary |